Research shows that your body produces vitamin D in multiple organs beyond the kidneys, including the spleen and intestines. A 2026 review in Current Opinion in Nephrology and Hypertension found that even patients without kidneys can still produce vitamin D through these alternative pathways, and that targeting vitamin D regulation in the intestines reduced secondary hyperparathyroidism in kidney disease models. This discovery suggests new treatments could help kidney disease patients more effectively.
Scientists have discovered that your body makes vitamin D in more places than previously thought. For decades, doctors believed the kidneys were the main organ responsible for activating vitamin D. New research shows that your spleen, intestines, and other organs can also produce and regulate vitamin D. This discovery is especially important for people with kidney disease, who may still benefit from vitamin D even when their kidneys aren’t working properly. These findings could lead to new treatments that work better and have fewer side effects than current approaches.
Key Statistics
A 2026 review published in Current Opinion in Nephrology and Hypertension found that the spleen and other organs can produce vitamin D and compensate for lost kidney function in mouse models of chronic kidney disease.
According to research reviewed by Gram, reducing vitamin D inactivation exclusively in the intestines attenuated secondary hyperparathyroidism in chronic kidney disease models, demonstrating that local tissue regulation offers therapeutic targets beyond the kidneys.
Clinical studies of calcifediol supplementation in anephric patients (those without kidneys) provided evidence for significant extra-renal vitamin D production, challenging the long-held belief that kidneys are the predominant organ for vitamin D synthesis.
The Quick Take
- What they studied: How vitamin D is made and controlled throughout the body, with a focus on organs other than the kidneys
- Who participated: This was a review of existing research, including clinical studies of kidney disease patients and laboratory studies using mice
- Key finding: Multiple organs including the spleen and intestines can produce and regulate vitamin D, not just the kidneys
- What it means for you: People with kidney disease may have more options for vitamin D treatment because their bodies can still make it in other ways. This could lead to better treatments with fewer side effects, though more research is needed before new therapies become available.
The Research Details
This was a comprehensive review of recent scientific discoveries about vitamin D regulation. The researchers examined new clinical studies involving patients without kidneys (anephric patients) and those with chronic kidney disease who received vitamin D supplements. They also reviewed laboratory studies using advanced technologies and mouse models to understand how different organs produce and break down vitamin D.
The review brought together findings from multiple research approaches to paint a complete picture of vitamin D production throughout the body. By combining clinical observations from real patients with controlled laboratory experiments, the researchers could identify which organs play important roles in vitamin D metabolism and how they compensate when the kidneys aren’t working properly.
Understanding where vitamin D is made and controlled throughout the body is crucial for developing better treatments. If doctors only focus on the kidneys, they might miss opportunities to help patients whose kidneys are failing. By identifying other organs that can produce vitamin D, researchers can develop targeted treatments that work through multiple pathways, potentially offering better results with fewer side effects.
This review synthesizes recent clinical studies and laboratory research published in peer-reviewed journals. The findings are supported by both human studies and animal models, which strengthens the evidence. However, as a review article, it summarizes existing research rather than conducting new experiments. The conclusions are based on emerging evidence, so some findings may need confirmation through larger clinical trials.
What the Results Show
According to Gram Research analysis, the spleen and other organs beyond the kidneys can produce vitamin D and compensate when kidney function is lost. This was demonstrated in studies of patients without kidneys who still showed vitamin D production, and in mouse models where removing kidney vitamin D production didn’t completely eliminate the body’s vitamin D supply.
Researchers also discovered that the intestines play a more active role in vitamin D regulation than previously recognized. By reducing vitamin D breakdown specifically in the intestines of mice with chronic kidney disease, scientists were able to reduce secondary hyperparathyroidism—a serious condition that develops when kidneys fail.
These findings challenge the traditional understanding that the kidneys are the only important site for vitamin D activation. Instead, the body appears to have a distributed system where multiple organs work together to maintain vitamin D levels and regulate its effects.
The research identified several other tissues beyond the kidney and spleen that participate in vitamin D metabolism. These tissue-specific findings suggest that vitamin D regulation is more complex than a single organ system. The discovery that local vitamin D metabolism in specific tissues can influence disease outcomes opens new possibilities for targeted treatments that work on individual organs rather than trying to fix everything through the kidneys.
For many decades, medical textbooks taught that the kidneys were the primary—and essentially only—organ responsible for converting vitamin D into its active form. This new research fundamentally shifts that understanding. Previous treatments for kidney disease patients focused on supplementing with vitamin D precursors and hoping the kidneys could still activate them. These new findings suggest that even when kidneys fail, the body has backup systems that can be targeted with new medications.
This review synthesizes existing research but doesn’t present new experimental data. Most of the laboratory findings come from mouse studies, which don’t always translate directly to humans. The clinical studies mentioned are recent but may involve relatively small numbers of patients. More large-scale human studies are needed to confirm these findings and determine which new treatments would be most effective and safe.
The Bottom Line
Current vitamin D supplementation approaches remain appropriate for kidney disease patients based on existing guidelines. However, people with kidney disease should be aware that new treatments targeting extra-renal vitamin D production may become available in the coming years. Discuss with your doctor whether you’re a candidate for emerging therapies as they become available. Confidence level: Moderate—the basic science is solid, but clinical applications are still in development.
People with chronic kidney disease or those who have lost kidney function should find this research particularly relevant, as it offers hope for better treatments. Healthcare providers treating kidney disease patients should stay informed about these developments. People with other vitamin D-related disorders may also benefit as treatments are developed. This research is less immediately relevant for people with healthy kidneys.
New treatments based on these discoveries are likely still several years away. Clinical trials will need to test whether targeting extra-renal vitamin D production actually improves patient outcomes. Expect to see preliminary results from early-stage trials within 2-3 years, with potential FDA approval of new therapies within 5-7 years.
Frequently Asked Questions
Can your body make vitamin D without kidneys?
Yes, according to recent research. Clinical studies of patients without kidneys showed they could still produce vitamin D through other organs like the spleen and intestines. This suggests the body has backup systems for vitamin D production beyond kidney function.
Where else does your body make vitamin D besides the kidneys?
The spleen, intestines, and several other tissues can produce and regulate vitamin D. A 2026 review identified multiple physiologically relevant tissues capable of vitamin D metabolism, offering potential targets for new treatments in kidney disease.
How does this help people with kidney disease?
These discoveries suggest new treatments could target vitamin D production in organs that still work, even when kidneys fail. This could provide better control of complications like secondary hyperparathyroidism and potentially offer therapies with fewer side effects.
When will new vitamin D treatments based on this research be available?
New treatments are likely still several years away. Clinical trials are needed to test whether targeting extra-renal vitamin D production improves patient outcomes. Expect preliminary results within 2-3 years and potential FDA approval within 5-7 years.
Should I change my vitamin D supplements if I have kidney disease?
Continue following your doctor’s current recommendations. While these research findings are promising, new treatments aren’t yet available. Discuss with your nephrologist whether you might be eligible for clinical trials testing emerging therapies.
Want to Apply This Research?
- Track vitamin D levels quarterly through blood tests if you have kidney disease, noting any changes in symptoms like bone pain or muscle weakness that might indicate vitamin D status changes
- Set reminders to discuss emerging vitamin D therapies with your nephrologist at each appointment, and ask whether you might be eligible for clinical trials testing new organ-targeted treatments
- Log any new medications or supplements related to vitamin D metabolism, track parathyroid hormone levels if monitored by your doctor, and note any changes in bone health or mineral metabolism symptoms over time
This article summarizes recent scientific research but is not medical advice. Vitamin D management in kidney disease requires individualized treatment based on your specific condition, kidney function, and blood test results. Do not change your vitamin D supplementation or medications without consulting your nephrologist or healthcare provider. The treatments discussed in this review are still in development and not yet available for clinical use. Always work with your healthcare team to determine the appropriate vitamin D strategy for your situation.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.